Find your path to Jigar
276 people in our graph share verified history with Jigar — schools, employers, funds. One of them is your warm intro.
Katrin GeyskensunlockedJigar: together at A.T. Kearney (1998–1999)
×4Jigar: together at A.T. Kearney
×7Jigar: together at Third Rock Ventures
About
Partner at Third Rock Ventures who joined in 2022, previously president and CEO of Constellation Pharmaceuticals until its 2021 acquisition and chief business officer at Jounce Therapeutics through its IPO. He holds an MBA from Columbia and a biochemistry/economics degree from Rutgers, and serves on boards at Flare Therapeutics, Synnovation, and TRIANA Biomedicines.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- Third Rock VenturesPartnercurrent2022 — present
- Third Rock VenturesBoard Member - Mass Medicines, Inc.current2025 — present
- Third Rock VenturesBoard Member - Synnovation, Inc.current2024 — present
- Third Rock VenturesBoard Member - Flare Therapeutics, Inc.current2022 — present
- TRIANA BiomedicinesChair of the Board of Directorscurrent2022 — presentGreater Boston
- Jounce Therapeutics, Inc.Chair of the Board of Directors2021 — 2023Greater Boston
- Constellation Pharmaceuticals, Inc. (Acquired)Chief Executive Officer2017 — 2021Cambridge, Massachusetts
- Jounce Therapeutics, Inc.Chief Business Officer2012 — 2017Greater Boston Area
- Constellation PharmaceuticalsHead of Corporate Development2009 — 2013Greater Boston Area
- Red Abbey Venture PartnersKauffman Fellow (2005-2007), Principal (2007-2009) Venture Partner (2009)2005 — 2009Baltimore, Maryland Area
- PfizerSummer - New Product Development - Marketing2004Greater New York City Area
- BiogenMarket & Business Development1999 — 2003Cambridge, Massachuesetts
- A.T. KearneyBusiness Analyst1998 — 1999Greater New York City Area
Skills & more
Biotechnology17Life Sciences12Pharmaceutical Industry8Venture Capital5Corporate Development3Business Development3Start-ups1StrategyDrug DiscoveryBusiness Strategy1BiopharmaceuticalsManagement
+2 more
Drug DevelopmentOncologyFrom Jigar's professional profile.
Investments
Board seats
Flare Therapeutics, Inc.Synnovation, Inc.Triana Biomedicines, Inc.
Per the firm's website.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alexis Borisy
General Partner at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Network1
Investors connected to Jigar in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jigar Raythatha?
- Partner at Third Rock Ventures who joined in 2022, previously president and CEO of Constellation Pharmaceuticals until its 2021 acquisition and chief business officer at Jounce Therapeutics through its IPO. He holds an MBA from Columbia and a biochemistry/economics degree from Rutgers, and serves on boards at Flare Therapeutics, Synnovation, and TRIANA Biomedicines.
- Where does Jigar Raythatha work?
- Jigar Raythatha is Partner at Third Rock Ventures.
- What does Jigar Raythatha invest in?
- Jigar Raythatha invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Jigar Raythatha sit on?
- Jigar Raythatha holds tracked board seats at Flare Therapeutics, Inc., Synnovation, Inc., Triana Biomedicines, Inc..
- Where did Jigar Raythatha go to school?
- Jigar Raythatha studied at Columbia Business School (MBA); Rutgers University (B.A., Biochemistry/Economics).
Same school
Also attended Columbia Business School1,173
Ryan PetersenFounder & CEO of FlexportAryo TehranianManaging Director at Mayfair Equity PartnersYibo NianInvestment Director at Intel CapitalKesha CashFounder & General Partner at Impact America FundMahati SridharPartner, Rise of the Rest at RevolutionGiuseppe IademarcoHead of Global Partnership at P101 Ventures
+ 1,167 more
Also attended Rutgers University307
Robin LiInvestor at GGV CapitalDominique LittleGovernment Affairs Lead at ParadigmGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersBill DeJianneSales Manager (Eastern U.S.) at Needham FundsMark FieldsInvestor at Alsop Louie PartnersMonal MehtaVenture Partner at Versant Ventures
+ 301 more
Shared employers
Also worked at TRIANA Biomedicines5
Also worked at Jounce Therapeutics, Inc.7
Jason FullerPartner at Deerfield Management CompanyDmitri WiederschainExecutive Officer at Crossbow TherapeuticsMonica GostissaChief Science Officer at Matrisome BioTatiana NovobrantsevaChief Scientific Officer at NextPoint TherapeuticsKomal JoshiExecutive Officer at Imbria PharmaceuticalsIgor FeldmanFounder at Verseau Therapeutics
+ 1 more
Also worked at Constellation Pharmaceuticals8
Bill AmsbaughCTO and Partner at Cure VenturesEmily GaudianoAssociate at SV Health InvestorsScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesJeff RoixVenture Partner at O2h VenturesAlexander TaylorPh.D. at Inductive BioMichael McKeownCo-founder and Head of Research at Bullseye Biosciences
+ 2 more
Also worked at Pfizer402
Abbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission BiocapitalBriggs MorrisonEntrepreneur Partner at MPM BioImpact
+ 396 more